[1] Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies[J]. Tissue Eng, 2001,7(2): 211-228.
[2] Konno M, Hamabe A, Hasegawa S, et al. Adipose-derived mesenchymal stem cells and regenerative medicine[J]. Develop Growth Differ, 2013, 55(3):309-318.
[3] Zhu XS, Shi W, Tai WP, et al. The comparition of biological characteristics and multilineage differentiation of bone marrow and adipose derived mesenchymal stem cells [J]. Cell Tissue Res, 2012,350(2):277-287.
[4] Madhu V, Kilanski A, Reghu N, et al. Expression of CD105 and CD34 receptors controls BMP-induced in vitro mineralization of mouse adipose-derived stem cells but does not predict their in vivo bone-forming potential[J]. J Orthop Res, 2015, 33(5):625-632.
[5] E LL, Xu LL, Wu X, et al. The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering [J]. Tissue Eng Part A, 2010,16(9): 2927-2940.
[6] Tobita M. Adipose-derived stem cells in dentistry [J]. J Oral Biosci, 2013,55(3):122-126.
[7] Zhang X, Guo J, Zhou YS, et al. The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells[J]. Tissue Eng Part B, 2014,20(1): 84-92.
[8] Bodle JC, Rubenstein CD, Phillips ME, et al. Primary Cilia: the chemical antenna regulating human adipose-derived stem cell osteogenesis[J]. PLoS One, 2013,8(5): e62554.
[9] Levi B, Hyun JS, Nelson ER, et al. Nonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repair [J]. Stem Cells, 2011,29(12):2018-2029.
[10] Guo J, Wu G. The signaling and functions of heterodimeric bone morphogenetic proteins [J]. Cytokine Growth Factor Rev, 2012,23(1-2):61-67.
[11] Kugimiya F, Yano F, Ohba S, et al. Mechanism of osteogenic induction by FK506 via BMP/Smad pathways[J]. Biochem Biophys Res Commun, 2005,338(2):872-879.
[12] Huang H, Song TJ, Li X, et al. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage [J]. Proc Natl Acad Sci U S A, 2009, 106(31):12670-12675.
[13] Mizrahi O, Sheyn D, Tawackoli W, et al. BMP-6 is more efficient in bone formation than BMP-2 when overexpressed in mesenchymal stem cells[J]. Gene Ther, 2013, 20(4):370-377.
[14] Lin L, Shen Q, Wei X, et al. Comparison of osteogenic potentials of BMP4 transduced stem cells from autologous bone marrow and fat tissue in a rabbit model of calvarial defects [J]. Calcif Tissue Int, 2009, 85(1):55-65.
[15] Vicente Lopez MA, Vazquez Garcia MN, Entrena A, et al. Low doses of bone morphogenetic protein 4 increase the survival of human adipose-derived stem cells maintaining their stemness and multipotency[J]. Stem Cells Dev, 2011,20(6):1011-1019.
[16] Shiraishi T, Sumita Y, Wakamastu Y, et al. Formation of engineered bone with adipose stromal cells from buccal fat pad[J]. J Dent Res, 2012, 91(6):592-597.
[17] Panetta NJ, Gupta DM, Lee JK, et al. Human adipose-derived stromal cells respond to and elaborate bone morphogenetic protein-2 during in vitro osteogenic differentiation[J]. Plast Reconstr Surg, 2010,125(2):483-493.
[18] Song I, Kim BS, Kim CS, et al. Effects of BMP-2 and vitamin D3 on the osteogenic differentiation of adipose stem cells[J]. Biochem Biophys Res Commun, 2011, 408(1):126-131.
[19] Levi B, James AW, Nelson ER, et al. Human adipose derived stromal cells heal critical size mouse calvarial defects [J]. PloS One, 2010, 5(7):e11177.
[20] Szpalski C, Nguyen PD, Cretiu VCE, et al. Bony engineering using time-release porous scaffolds to provide sustained growth factor delivery[J]. J Craniofac Surg, 2012, 23(3):638-644.
[21] Khojasteh A, Behnia H, Naghdi N, et al. Effects of different growth factors and carriers on bone regeneration: a systematic review [J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013, 116(6):e405-e423.
[22] Lu Z, Roohani-Esfahani SI, Li J, et al. Synergistic effect of nanomaterials and BMP-2 signalling in inducing osteogenic differentiation of adipose tissue-derived mesenchymal stem cells[J]. Nanomedicine, 2015, 11(1):219-228.
[23] Vila OF, Martino MM, Nebuloni L, et al. Bioluminescent and micro-computed tomography imaging of bone repair induced by fibrin-binding growth factors [J]. Acta Biomater, 2014, 10(10):4377-4389.
[24] Peterson B, Zhang J, Iglesias R. Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue [J]. Tissue Eng Part A, 2005, 11(1-2):120-129.
[25] Liao YH, Chang YH, Sunga LY, et al. Osteogenic differentiation of adipose-derived stem cells and calvarial defect repair using baculovirus-mediated co-expression of BMP-2 and miR-148b [J]. Biomaterials, 2014, 35(18):4901-4910.
[26] Lin CY, Wang YH, Li KC, et al. Healing of massive segmental femoral bone defects in minipigs by allogenic ASCs engineered with FLPo/Frt-based baculovirus vectors [J]. Biomaterials, 2015, 50:98-106.
[27] Behr B, Tang C, Germann G, et al. Locally applied VADSCular endothelial growth factor a increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation[J]. Stem Cells, 2011, 29(2):286-296.
[28] Fan J, Park H, Tan S, et al. Enhanced osteogenesis of adipose derived stem cells with noggin suppression and delivery of BMP-2 [J]. PloS One, 2013, 8(8):e72474.
[29] Levi B, Nelson ER, Hyun JS, et al. Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor[J]. Plast Reconstr Surg, 2012, 129(1):53-66.
[30] Ramasubramanian A, Shiigi S, Lee GK, et al. Non-viral delivery of inductive and suppressive genes to adipose-derived stem cells for osteogenic differentiation[J]. Pharm Res, 2011, 28(6):1328-1337.
[31] Zhou YS, Liu, YS, Tan JG. Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro[J]. Chin Med J (Engl), 2006, 119(15):1278-1286.
[32] Wang CZ, Fu YC, Jian SC, et al. Synthesis and characterization of cationic polymeric nanoparticles as simvastatin carriers for enhancing the osteogenesis of bone marrow mesenchymal stem cells[J]. J Colloid Interface Sci, 2014, 432(15):190-199.
[33] Zhou C, Lin Y. Osteogenic differentiation of adipose-derived stem cells promoted by quercetin[J]. Cell Proliferat, 2014, 47(2):124-132.
[34] Quarto N, Senarath-Yapa K, Renda A, et al. TWIST1 Silencing enhances in vitro and in vivo osteogenic differentiation of human adipose-derived stem cells by triggering activation of BMP-ERK/FGF signaling and TAZ upregulation[J]. Stem Cells, 2015, 33(3):833-847.
[35] Zhang X, Guo J, Zhou Y, et al. The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells[J]. Tissue Eng Part B Rev,2014, 20(1):84-92.
[36] Jeon MJ, Kim JA, Kwon SH, et al. Activation of peroxisome proliferator-activated receptor-gamma inhibits the Runx2- mediated transcription of osteocalcin in osteoblasts[J]. J Biol Chem, 2003, 278(26):23270-23277.
[37] Lee JS, Lee JM, Im GI. Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogenesis of adipose stem cells [J]. Biomaterials, 2011, 32(3):760-768.
[38] Bailey AM, Kapur S, Katz AJ. Characterization of adipose-derived stem cells: an update[J]. Curr Stem Cell Res Ther, 2010, 5(2):95-102. |